These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14694062)

  • 1. Hereditary elevation of angiotensin converting enzyme suggesting neurosarcoidosis.
    Linnebank M; Kesper K; Jeub M; Urbach H; Wüllner U; Klockgether T; Schmidt S
    Neurology; 2003 Dec; 61(12):1819-20. PubMed ID: 14694062
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system sarcoidosis.
    Rubinstein I
    J Neurosurg; 1986 Aug; 65(2):265. PubMed ID: 3014084
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and neurosarcoidosis.
    Ahmad S
    Chest; 1991 Apr; 99(4):1054. PubMed ID: 1849067
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme.
    Kitajima S; Sakai N; Furuichi K; Tomokage M; Hara A; Kitagawa K; Sawada Kitamura S; Zen Y; Nakada M; Kaneko S; Wada T
    Mod Rheumatol; 2010 Oct; 20(5):506-10. PubMed ID: 20499262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis.
    Dale JC; O'Brien JF
    Mayo Clin Proc; 1999 May; 74(5):535. PubMed ID: 10319092
    [No Abstract]   [Full Text] [Related]  

  • 6. [A suspicious case of central neurosarcoidosis, manifesting as a progressive gait disturbance with a lesion in the central gray matter of the midbrain, accompanying an elevated level of angiotensin converting enzyme in the cerebrospinal fluid].
    Ito Y; Nakazato Y; Tomioka R; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2007 Aug; 47(8):512-5. PubMed ID: 17882944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
    Arun T; Pattison L; Palace J
    Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychotic symptoms and cognitive impairment in neurosarcoidosis. Case report and review of literature].
    Gaweł M; Domitrz I; Dziewulska D; Dabrowski A; Przyjałkowski W; Gołebiowski M; Kwieciński H
    Psychiatr Pol; 2012; 46(6):1099-108. PubMed ID: 23479950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of neurosarcoidosis--necessity of biopsy.
    Stjepanović MI; Vucinić VM; Jovanović D; Mijajlović M; Trifunović VS; Stjepanović MM
    Med Pregl; 2014; 67(3-4):97-9. PubMed ID: 24961051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurosarcoidosis in the Pontevedra-Salnes health district].
    Puy-Núñez A; Canneti B; Cabo-López I; del Campo Amigo M; Mouriño-Sestelo MA; Suárez-Gil AP; Regal AR
    Rev Neurol; 2015 Apr; 60(8):381-3. PubMed ID: 25857863
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetes insipidus due to neurosarcoidosis].
    Skowasch D; Pabst S; Wilhelm K; Grohé C
    Pneumologie; 2011 Aug; 65(8):496-7. PubMed ID: 21544752
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of cerebrospinal fluid ACE level in aseptic meningitis: diagnostic?
    Saha BK; Saha A; Beegle S
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psycho-neurological symptoms and raised angiotensin-converting enzyme in cerebrospinal fluid in a patient with sarcoidosis beginning in the central nervous system].
    Sakakibara R; Nakajima M; Hirayama K; Yagihashi M
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1227-31. PubMed ID: 1964883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased serum activity of angiotensin-converting enzyme (ACE): indication of sarcoidosis? A 'Bayesian' approach].
    Kramers C; Deinum J
    Ned Tijdschr Geneeskd; 2003 Mar; 147(11):473-6. PubMed ID: 12677943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compressive optic neuropathy from neurosarcoidosis.
    Lally E; Murchison AP; Moster ML; Bilyk JR
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):e79. PubMed ID: 25427128
    [No Abstract]   [Full Text] [Related]  

  • 16. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis.
    Wang L; Li Y
    J Neurol Sci; 2015 Aug; 355(1-2):64-7. PubMed ID: 26027786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
    Jones DB; Mitchell D; Horn DB; Edwards CR
    Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
    Bridel C; Courvoisier DS; Vuilleumier N; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():1-3. PubMed ID: 26198911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.
    Sakushima K; Yabe I; Nakano F; Yoshida K; Tajima Y; Houzen H; Maruo Y; Sasaki H
    J Neurol; 2011 Dec; 258(12):2163-7. PubMed ID: 21553080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF-ACE activity in probable CNS neurosarcoidosis.
    Tahmoush AJ; Amir MS; Connor WW; Farry JK; Didato S; Ulhoa-Cintra A; Vasas JM; Schwartzman RJ; Israel HL; Patrick H
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):191-7. PubMed ID: 12405488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.